145 related articles for article (PubMed ID: 7439247)
1. Paracetamol pharmacokinetics in thyroid disease.
Forfar JC; Pottage A; Toft AD; Irvine WJ; Clements JA; Prescott LF
Eur J Clin Pharmacol; 1980 Oct; 18(3):269-73. PubMed ID: 7439247
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man.
Nicoloff JT; Low JC; Dussault JH; Fisher DA
J Clin Invest; 1972 Mar; 51(3):473-83. PubMed ID: 4110897
[TBL] [Abstract][Full Text] [Related]
3. Oxazepam pharmacokinetics in thyroid disease.
Scott AK; Khir AS; Bewsher PD; Hawksworth GM
Br J Clin Pharmacol; 1984 Jan; 17(1):49-53. PubMed ID: 6419761
[TBL] [Abstract][Full Text] [Related]
4. Leptin and the pituitary-thyroid axis: a comparative study in lean, obese, hypothyroid and hyperthyroid subjects.
Pinkney JH; Goodrick SJ; Katz J; Johnson AB; Lightman SL; Coppack SW; Mohamed-Ali V
Clin Endocrinol (Oxf); 1998 Nov; 49(5):583-8. PubMed ID: 10197072
[TBL] [Abstract][Full Text] [Related]
5. Effects of thyroid dysfunction on propranolol kinetics.
Riddell JG; Neill JD; Kelly JG; McDevitt DG
Clin Pharmacol Ther; 1980 Nov; 28(5):565-74. PubMed ID: 7438675
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of thyrotrophin-releasing hormone in patients in different thyroid states.
Iversen E
J Endocrinol; 1991 Jan; 128(1):153-9. PubMed ID: 1900321
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of oxazepam and metabolism of paracetamol in severe hypothyroidism.
Sonne J; Boesgaard S; Poulsen HE; Loft S; Hansen JM; Døssing M; Andreasen F
Br J Clin Pharmacol; 1990 Nov; 30(5):737-42. PubMed ID: 2271373
[TBL] [Abstract][Full Text] [Related]
8. Drug metabolism in thyroid disease.
Eichelbaum M
Clin Pharmacokinet; 1976; 1(5):339-50. PubMed ID: 797503
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of theophylline in hyperthyroid and hypothyroid patients with chronic obstructive pulmonary disease.
Pokrajac M; Simić D; Varagić VM
Eur J Clin Pharmacol; 1987; 33(5):483-6. PubMed ID: 3428340
[TBL] [Abstract][Full Text] [Related]
10. Amiodarone pharmacokinetics. III. Influence of thyroid dysfunction on amiodarone absorption and disposition.
Weir SJ; Ueda CT
J Pharmacol Exp Ther; 1988 Sep; 246(3):1026-32. PubMed ID: 3418508
[TBL] [Abstract][Full Text] [Related]
11. Plasma and urinary digoxin in thyroid dysfunction.
Shenfield GM; Thompson J; Horn DB
Eur J Clin Pharmacol; 1977 Dec; 12(6):437-43. PubMed ID: 598418
[TBL] [Abstract][Full Text] [Related]
12. Alterations in magnesium and zinc metabolism in thyroid disease.
Dolev E; Deuster PA; Solomon B; Trostmann UH; Wartofsky L; Burman KD
Metabolism; 1988 Jan; 37(1):61-7. PubMed ID: 3336286
[TBL] [Abstract][Full Text] [Related]
13. The calcium pump of cardiac sarcoplasmic reticulum. Functional alterations at different levels of thyroid state in rabbits.
Suko J
J Physiol; 1973 Feb; 228(3):563-82. PubMed ID: 4267211
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle and whole body protein turnover in thyroid disease.
Morrison WL; Gibson JN; Jung RT; Rennie MJ
Eur J Clin Invest; 1988 Feb; 18(1):62-8. PubMed ID: 3130261
[TBL] [Abstract][Full Text] [Related]
15. Early kinetics of thyroid trap in normal human patients and in thyroid diseases.
Bazin JP; Fragu P; Di Paola R; Di Paola M; Tubiana M
Eur J Nucl Med; 1981; 6(7):317-26. PubMed ID: 6166476
[TBL] [Abstract][Full Text] [Related]
16. Altered plasma half-lives of antipyrine, propylthiouracil, and methimazole in thyroid dysfunction.
Vesell ES; Shapiro JR; Passananti T; Jorgensen H; Shively CA
Clin Pharmacol Ther; 1975 Jan; 17(1):48-56. PubMed ID: 1122669
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic properties and bioavailability of methimazole.
Jansson R; Lindström B; Dahlberg PA
Clin Pharmacokinet; 1985; 10(5):443-50. PubMed ID: 4042519
[TBL] [Abstract][Full Text] [Related]
18. Thyroid hormones modulate serum leptin levels: observations in thyrotoxic and hypothyroid women.
Diekman MJ; Romijn JA; Endert E; Sauerwein H; Wiersinga WM
Thyroid; 1998 Dec; 8(12):1081-6. PubMed ID: 9920361
[TBL] [Abstract][Full Text] [Related]
19. Metabolic clearance and production rates of 3,3',5-triiodothyronine in hyperthyroid, euthyroid, and hypothyroid subjects.
Smallridge RC; Wartofsky L; Desjardins RE; Burman KD
J Clin Endocrinol Metab; 1978 Aug; 47(2):345-9. PubMed ID: 263302
[TBL] [Abstract][Full Text] [Related]
20. Digoxin kinetics in patients with thyroid dysfunction.
Lawrence JR; Sumner DJ; Kalk WJ; Ratcliffe WA; Whiting B; Gray K; Lindsay M
Clin Pharmacol Ther; 1977 Jul; 22(1):7-13. PubMed ID: 872497
[No Abstract] [Full Text] [Related]
[Next] [New Search]
